← back to search

Ronald W. Busuttil

University of California, Los Angeles · US
🔎 Find collaborators in Surgery · Hepatology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Surgery · Hepatology
Research interest
Research interests include Organ Transplantation Techniques and Outcomes, Liver Disease and Transplantation, Liver Disease Diagnosis and Treatment, and Renal Transplantation Outcomes and Treatments.
h-index
116
citations
51,390
works
1,005
NIH funding
primary concept
Medicine
email

Recent publications

Pretransplant circulating cTfh17 and donor-reactive T follicular helper responses distinguish liver transplant recipients who develop ischemia-reperfusion injury and donor-specific antibody
American Journal of Transplantation 2026cited by 0position: contributordoi
HCC EV ECG score: An extracellular vesicle-based protein assay for detection of early-stage hepatocellular carcinoma.
2023cited by 74position: contributordoi
Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant Consortium
Liver Transplantation 2023cited by 43position: middledoi
Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant Consortium.
2023cited by 33position: contributordoi
Disulfide-HMGB1 signals through TLR4 and TLR9 to induce inflammatory macrophages capable of innate-adaptive crosstalk in human liver transplantation
American Journal of Transplantation 2023cited by 30position: middledoi
Disulfide-HMGB1 signals through TLR4 and TLR9 to induce inflammatory macrophages capable of innate-adaptive crosstalk in human liver transplantation
American Journal of Transplantation 2023cited by 29position: contributordoi
Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma
JAMA Surgery 2022cited by 141position: middledoi
HCC EV ECG score: An extracellular vesicle‐based protein assay for detection of early‐stage hepatocellular carcinoma
Hepatology 2022cited by 89position: middledoi
Low-dose aspirin confers protection against acute cellular allograft rejection after primary liver transplantation.
2022cited by 13position: contributordoi
Circulating Tumor Cell-Based Messenger RNA Scoring System for Prognostication of Hepatocellular Carcinoma: Translating Tissue-Based Messenger RNA Profiling Into a Noninvasive Setting.
2022cited by 12position: contributordoi
T‐Cell Immunoglobulin and Mucin Domain‐Containing Protein‐4 Is Critical for Kupffer Cell Homeostatic Function in the Activation and Resolution of Liver Ischemia Reperfusion Injury
Hepatology 2021cited by 78position: middledoi
T-Cell Immunoglobulin and Mucin Domain-Containing Protein-4 Is Critical for Kupffer Cell Homeostatic Function in the Activation and Resolution of Liver Ischemia Reperfusion Injury.
2021cited by 74position: contributordoi
Disulfide High-Mobility Group Box 1 Drives Ischemia-Reperfusion Injury in Human Liver Transplantation.
2021cited by 64position: contributordoi
A 3‐Decade, Single‐Center Experience of Liver Transplantation for Cholangiocarcinoma: Impact of Era, Tumor Size, Location, and Neoadjuvant Therapy
Liver Transplantation 2021cited by 51position: middledoi
A 3‐Decade, Single‐Center Experience of Liver Transplantation for Cholangiocarcinoma: Impact of Era, Tumor Size, Location, and Neoadjuvant Therapy
Liver Transplantation 2021cited by 48position: contributordoi
Donor Hepatic Occult Collagen Deposition Predisposes to Peritransplant Stress and Impacts Human Liver Transplantation.
2021cited by 11position: contributordoi
Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non–Hepatocellular Carcinoma Factors
Liver Transplantation 2021cited by 8position: contributordoi
Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring
Nature Communications 2020cited by 227position: middledoi
Ischemia-reperfusion injury and its relationship with early allograft dysfunction in liver transplant patients
American Journal of Transplantation 2020cited by 165position: middledoi
Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria
Hepatology 2020cited by 113position: middledoi
Hepatocellular Carcinoma–Circulating Tumor Cells Expressing PD‐L1 Are Prognostic and Potentially Associated With Response to Checkpoint Inhibitors
Hepatology Communications 2020cited by 100position: middledoi
Hepatocellular Carcinoma-Circulating Tumor Cells Expressing PD-L1 Are Prognostic and Potentially Associated With Response to Checkpoint Inhibitors.
2020cited by 90position: contributordoi
Functional crosstalk between myeloid Foxo1–β-catenin axis and Hedgehog/Gli1 signaling in oxidative stress response
Cell Death and Differentiation 2020cited by 90position: middledoi
Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria.
2020cited by 79position: contributordoi
Disulfide High‐Mobility Group Box 1 Drives Ischemia‐Reperfusion Injury in Human Liver Transplantation
Hepatology 2020cited by 74position: middledoi
Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury
Journal of Clinical Investigation 2020cited by 55position: middledoi
Ischemia-reperfusion Injury in Allogeneic Liver Transplantation: A Role of CD4 T Cells in Early Allograft Injury
Transplantation 2020cited by 43position: middledoi
Multi-Center Analysis of Liver Transplantation for Combined Hepatocellular Carcinoma-Cholangiocarcinoma Liver Tumors
Journal of the American College of Surgeons 2020cited by 37position: middledoi
Farnesoid X Receptor Activation Protects Liver From Ischemia/Reperfusion Injury by Up-Regulating Small Heterodimer Partner in Kupffer Cells.
2020cited by 27position: contributordoi
Human Antigen R (HuR): A Regulator of Heme Oxygenase-1 Cytoprotection in Mouse and Human Liver Transplant Injury.
2020cited by 19position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Jerzy W. Kupiec‐Weglinski · Riverside Transplantation Institute28 papers (2012–2026)Vatche G. Agopian · California NanoSystems Institute24 papers (2012–2022)Fady M. Kaldas · UCLA Medical Center24 papers (2012–2026) · 19 papers (2019–2026)Douglas G. Farmer · UCLA Medical Center18 papers (2012–2021)Ali Zarrinpar · Florida College15 papers (2012–2020)Yuan Zhai · Shanghai Jiao Tong University13 papers (2012–2026)Bibo Ke · UCLA Medical Center12 papers (2012–2020)Jonathan R. Hiatt · University of California, Los Angeles10 papers (2012–2018)Hasan Yersiz · University of California, Los Angeles10 papers (2012–2021)Shi Yue · Shanghai University of Sport9 papers (2012–2018)Elaine F. Reed · UCLA Medical Center8 papers (2015–2023)Rebecca A. Sosa · UCLA Medical Center8 papers (2017–2023)Bita V. Naini · University of California System8 papers (2013–2023)Johnny C. Hong · Mercy St. Vincent Medical Center7 papers (2012–2021)Henrik Petrowsky · University of Zurich7 papers (2012–2017)Daniela Markovic · Core Laboratories (United States)7 papers (2012–2020)Xiu‐Da Shen · University of California, Los Angeles6 papers (2012–2014)Vatche Agopian · Los Angeles Medical Center6 papers (2020–2023)Robert S. Venick · University of California, Los Angeles6 papers (2015–2018)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Surgery · Hepatology →